Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 5, 2011, Pages 615-623

  Aldawsari, Hibah ^a   Raj, Behin Sundara ^a   Edrada Ebel, RuAngelie ^a   Blatchford, David R ^a   Tate, Rothwelle J ^a   Tetley, Laurence ^b   Dufès, Christine ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Amino acid; Cancer therapy; Gene delivery; Gene expression; Polyethylenimine

Indexed keywords

AFTER-TREATMENT; CANCER THERAPY; CELL PENETRATION; CLINICAL APPLICATION; ENHANCED GENE EXPRESSION; GALACTOSIDASES; GENE DELIVERY; GENE DELIVERY SYSTEMS; INTRAVENOUS ADMINISTRATION; POLYETHYLENIMINE POLYPLEXES; POLYETHYLENIMINES; POLYPLEXES; THERAPEUTIC GENES; TUMOR MODELS;

AMINO ACIDS; ARGININE; BEARINGS (STRUCTURAL); DISEASES; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; ONCOLOGY; TUMORS;

GENE EXPRESSION;

ARGININE POLYETHYLENEIMINE; BETA GALACTOSIDASE; LEUCINE POLYETHYLENEIMINE; LYSINE POLYETHYLENEIMINE; PLASMID DNA; POLYETHYLENEIMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; MATERIALS TESTING; MOUSE; NONHUMAN;

ANIMALS; ARGININE; BETA-GALACTOSIDASE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LEUCINE; LYSINE; MICE; MICE, INBRED BALB C; NEOPLASMS; POLYETHYLENEIMINE;

MUS;

EID: 80053219720     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.01.016     Document Type: Article

References (22)

1. Thomas M., Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 2003, 62:27-34.
2. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002, 245:1-7.
3. Tung C.H., Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 2003, 55:281-294.
4. Nakanishi M., Eguchi A., Akuta T., Nagoshi E., Fujita S., Okabe J., et al. Basic peptides as functional components of non-viral gene transfer vehicles. Curr Prot Pept Sci 2003, 4:141-150.
5. Choi J.S., Nam K., Park J.Y., Kim J.B., Lee J.K., Park J.S. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine. J Control Release 2004, 99:445-456.
6. Kim T.I., Baek J.U., Bai C.Z., Park J.S. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials 2007, 28:2061-2067.
7. Gao Y., Xu Z., Chen S., Gu W., Chen L., Li Y. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: in vitro characteristics and transfection efficiency. Int J Pharm 2008, 359:241-246.
8. Kim T.I., Ou M., Lee M., Kim S.W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 2009, 30:658-664.
9. Kono K., Akiyama H., Takahashi T., Takagishi T., Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconjug Chem 2005, 16:208-214.
10. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999, 96:5177-5181.
11. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 2001, 22:471-480.
12. Sung S.J., Min S.H., Cho K.Y., Lee S., Min Y.J., Yeom Y.I., et al. Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol Pharm Bull 2003, 26:492-500.
13. Dufès C., Schätzlein A.G., Tetley L., Gray A.I., Watson D.G., Olivier J.C., et al. Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. Pharm Res 2000, 17:1250-1258.
14. Koppu S., Oh Y.J., Edrada-Ebel R., Blatchford D.R., Tetley L., Tate R.J., et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J Control Release 2010, 143:215-221.
15. Zinselmeyer B.H., Mackay S.P., Schätzlein A.G., Uchegbu I.F. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 2002, 19:960-967.
16. Zinselmeyer B.H., Beggbie N., Uchegbu I.F., Schätzlein A.G. Quantification of beta-galactosidase activity after non-viral transfection in vivo. J Control Release 2003, 91:201-208.
17. Zhu J., Tang A., Law L.P., Feng M., Ho K.M., Lee D.K., et al. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Bioconjug Chem 2005, 16:139-147.
18. Mahato R.I., Smith L.C., Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Adv Genet 1999, 41:95-156.
19. Choi H.S., Kim H.H., Yang J.M., Shin S. An insight into the gene delivery mechanism of the arginine peptide system: role of the peptide/DNA complex size. Biochim Biophys Acta 2006, 1760:1604-1612.
20. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 2001, 12:1005-1011.
21. Fujita T., Furuhata M., Hattori Y., Kawakami H., Toma K., Maitani Y. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J Control Release 2008, 129:124-127.
22. Kim H.S., Song I.H., Kim J.C., Kim E.J., Jang D.O., Park Y.S. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate). J Control Release 2006, 115:234-241.